 Jon Vogel
Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rectal Neoplasms | 9 | 2025 | 159 | 2.730 |
Why?
| | Laparoscopy | 7 | 2021 | 481 | 1.710 |
Why?
| | Colectomy | 6 | 2022 | 106 | 1.250 |
Why?
| | Propensity Score | 2 | 2019 | 377 | 1.010 |
Why?
| | Neoadjuvant Therapy | 6 | 2025 | 465 | 0.950 |
Why?
| | Diverticulitis, Colonic | 1 | 2025 | 10 | 0.930 |
Why?
| | Sigmoid Diseases | 1 | 2025 | 14 | 0.920 |
Why?
| | Colitis, Ulcerative | 3 | 2023 | 148 | 0.880 |
Why?
| | Proctocolectomy, Restorative | 3 | 2023 | 23 | 0.870 |
Why?
| | Critical Pathways | 1 | 2025 | 109 | 0.830 |
Why?
| | Adenocarcinoma | 6 | 2025 | 925 | 0.830 |
Why?
| | Colon, Sigmoid | 1 | 2021 | 21 | 0.670 |
Why?
| | Intestinal Volvulus | 1 | 2021 | 23 | 0.650 |
Why?
| | Ambulatory Care | 1 | 2025 | 609 | 0.650 |
Why?
| | Rectal Prolapse | 1 | 2020 | 24 | 0.610 |
Why?
| | Abdominal Pain | 1 | 2021 | 149 | 0.610 |
Why?
| | Colonic Polyps | 1 | 2021 | 87 | 0.600 |
Why?
| | Colonic Neoplasms | 1 | 2022 | 257 | 0.600 |
Why?
| | Watchful Waiting | 3 | 2025 | 90 | 0.580 |
Why?
| | Digestive System Surgical Procedures | 4 | 2020 | 112 | 0.580 |
Why?
| | Clinical Decision-Making | 2 | 2021 | 363 | 0.540 |
Why?
| | Colonic Diseases | 2 | 2017 | 37 | 0.520 |
Why?
| | Colorectal Neoplasms | 2 | 2025 | 866 | 0.500 |
Why?
| | Robotic Surgical Procedures | 1 | 2019 | 185 | 0.500 |
Why?
| | Anti-Bacterial Agents | 2 | 2025 | 1923 | 0.490 |
Why?
| | Fecal Microbiota Transplantation | 1 | 2016 | 27 | 0.480 |
Why?
| | Colorectal Surgery | 4 | 2021 | 30 | 0.470 |
Why?
| | Clostridium Infections | 1 | 2016 | 74 | 0.460 |
Why?
| | Neoplasm Staging | 6 | 2024 | 1471 | 0.390 |
Why?
| | Retrospective Studies | 13 | 2025 | 17291 | 0.360 |
Why?
| | Ileostomy | 4 | 2023 | 26 | 0.350 |
Why?
| | Neoplasm Recurrence, Local | 3 | 2025 | 1149 | 0.320 |
Why?
| | Survival Rate | 5 | 2025 | 2090 | 0.310 |
Why?
| | Margins of Excision | 2 | 2021 | 50 | 0.310 |
Why?
| | Middle Aged | 18 | 2025 | 36215 | 0.310 |
Why?
| | Aged | 15 | 2025 | 26153 | 0.300 |
Why?
| | Databases, Factual | 4 | 2019 | 1490 | 0.290 |
Why?
| | Nomograms | 1 | 2009 | 59 | 0.290 |
Why?
| | Humans | 29 | 2025 | 145474 | 0.250 |
Why?
| | Male | 20 | 2025 | 72842 | 0.240 |
Why?
| | Surgeons | 2 | 2021 | 340 | 0.240 |
Why?
| | Digital Rectal Examination | 1 | 2025 | 10 | 0.240 |
Why?
| | Surgical Wound Infection | 1 | 2009 | 329 | 0.230 |
Why?
| | Postoperative Complications | 6 | 2023 | 2970 | 0.230 |
Why?
| | Quality Improvement | 4 | 2025 | 1295 | 0.230 |
Why?
| | Aged, 80 and over | 7 | 2025 | 8333 | 0.230 |
Why?
| | Circulating Tumor DNA | 1 | 2025 | 46 | 0.220 |
Why?
| | Female | 19 | 2025 | 78844 | 0.210 |
Why?
| | Treatment Outcome | 6 | 2023 | 11772 | 0.210 |
Why?
| | Tomography, X-Ray Computed | 3 | 2022 | 2769 | 0.200 |
Why?
| | Obesity | 1 | 2017 | 3116 | 0.190 |
Why?
| | Acute Disease | 1 | 2025 | 1036 | 0.180 |
Why?
| | Disease Management | 3 | 2021 | 653 | 0.180 |
Why?
| | Carcinoembryonic Antigen | 1 | 2022 | 40 | 0.180 |
Why?
| | Sigmoidoscopy | 1 | 2021 | 14 | 0.170 |
Why?
| | Length of Stay | 3 | 2017 | 1349 | 0.160 |
Why?
| | Expert Testimony | 1 | 2021 | 42 | 0.160 |
Why?
| | Endoscopic Mucosal Resection | 1 | 2021 | 38 | 0.160 |
Why?
| | Anastomosis, Surgical | 1 | 2021 | 162 | 0.160 |
Why?
| | Interdisciplinary Communication | 1 | 2021 | 200 | 0.150 |
Why?
| | Adult | 8 | 2025 | 40777 | 0.150 |
Why?
| | Hair Removal | 1 | 2019 | 2 | 0.150 |
Why?
| | Pilonidal Sinus | 1 | 2019 | 4 | 0.150 |
Why?
| | Aftercare | 1 | 2021 | 222 | 0.150 |
Why?
| | Sclerosing Solutions | 1 | 2019 | 10 | 0.150 |
Why?
| | Phenol | 1 | 2019 | 15 | 0.140 |
Why?
| | Fibrin Tissue Adhesive | 1 | 2019 | 20 | 0.140 |
Why?
| | Tissue Adhesives | 1 | 2019 | 21 | 0.140 |
Why?
| | Patient Selection | 2 | 2022 | 738 | 0.140 |
Why?
| | Combined Modality Therapy | 1 | 2022 | 1266 | 0.140 |
Why?
| | Biomarkers, Tumor | 1 | 2025 | 1321 | 0.140 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2019 | 222 | 0.140 |
Why?
| | United States | 6 | 2024 | 16098 | 0.130 |
Why?
| | Drainage | 1 | 2019 | 185 | 0.130 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2022 | 534 | 0.130 |
Why?
| | Crohn Disease | 1 | 2020 | 260 | 0.120 |
Why?
| | Digestive System Neoplasms | 1 | 2016 | 9 | 0.120 |
Why?
| | Intestinal Mucosa | 1 | 2021 | 675 | 0.110 |
Why?
| | Sigmoid Neoplasms | 1 | 2015 | 5 | 0.110 |
Why?
| | Patient Care Planning | 1 | 2016 | 170 | 0.110 |
Why?
| | Diagnosis-Related Groups | 1 | 2014 | 35 | 0.110 |
Why?
| | Neuroendocrine Tumors | 1 | 2016 | 119 | 0.110 |
Why?
| | Salvage Therapy | 2 | 2025 | 165 | 0.100 |
Why?
| | Venules | 1 | 2013 | 14 | 0.100 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1547 | 0.100 |
Why?
| | Emergency Service, Hospital | 1 | 2025 | 2381 | 0.100 |
Why?
| | Hair Follicle | 1 | 2013 | 49 | 0.100 |
Why?
| | Venous Thromboembolism | 2 | 2021 | 328 | 0.090 |
Why?
| | Algorithms | 1 | 2021 | 1845 | 0.090 |
Why?
| | Stem Cell Niche | 1 | 2013 | 57 | 0.090 |
Why?
| | Prognosis | 3 | 2025 | 4316 | 0.090 |
Why?
| | Prospective Studies | 2 | 2023 | 8057 | 0.090 |
Why?
| | Hand-Assisted Laparoscopy | 1 | 2011 | 4 | 0.080 |
Why?
| | Risk Assessment | 1 | 2021 | 3747 | 0.080 |
Why?
| | Cell Communication | 1 | 2013 | 328 | 0.080 |
Why?
| | Patient Care Team | 1 | 2016 | 696 | 0.080 |
Why?
| | Rectum | 1 | 2011 | 182 | 0.080 |
Why?
| | Enteritis | 1 | 2010 | 104 | 0.070 |
Why?
| | Disease-Free Survival | 2 | 2025 | 767 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 1 | 2022 | 3904 | 0.070 |
Why?
| | Follow-Up Studies | 3 | 2025 | 5423 | 0.070 |
Why?
| | Colon | 1 | 2011 | 309 | 0.070 |
Why?
| | Stem Cells | 1 | 2013 | 628 | 0.070 |
Why?
| | Microsatellite Instability | 1 | 2008 | 55 | 0.070 |
Why?
| | Intensive Care Units | 1 | 2014 | 924 | 0.070 |
Why?
| | Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2008 | 41 | 0.070 |
Why?
| | Liquid Biopsy | 1 | 2025 | 15 | 0.060 |
Why?
| | Models, Statistical | 1 | 2009 | 671 | 0.060 |
Why?
| | Risk Factors | 4 | 2014 | 10885 | 0.050 |
Why?
| | Chemoradiotherapy, Adjuvant | 1 | 2023 | 44 | 0.050 |
Why?
| | Practice Guidelines as Topic | 2 | 2021 | 1581 | 0.050 |
Why?
| | Induction Chemotherapy | 1 | 2023 | 88 | 0.050 |
Why?
| | Pouchitis | 1 | 2021 | 8 | 0.040 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2023 | 423 | 0.040 |
Why?
| | Chemoradiotherapy | 1 | 2023 | 239 | 0.040 |
Why?
| | Quality-Adjusted Life Years | 1 | 2021 | 123 | 0.040 |
Why?
| | Early Detection of Cancer | 1 | 2025 | 485 | 0.040 |
Why?
| | Dilatation | 1 | 2020 | 71 | 0.040 |
Why?
| | Severity of Illness Index | 2 | 2020 | 2930 | 0.040 |
Why?
| | Constriction, Pathologic | 1 | 2020 | 249 | 0.040 |
Why?
| | Practice Patterns, Physicians' | 1 | 2008 | 1371 | 0.040 |
Why?
| | Lasers, Solid-State | 1 | 2019 | 22 | 0.040 |
Why?
| | Surgical Flaps | 1 | 2019 | 142 | 0.030 |
Why?
| | Incidental Findings | 1 | 2016 | 81 | 0.030 |
Why?
| | Endoscopy, Digestive System | 1 | 2016 | 142 | 0.030 |
Why?
| | Time Factors | 1 | 2025 | 7123 | 0.030 |
Why?
| | Ohio | 1 | 2014 | 146 | 0.030 |
Why?
| | Societies, Medical | 1 | 2019 | 899 | 0.030 |
Why?
| | Reimbursement, Incentive | 1 | 2014 | 42 | 0.030 |
Why?
| | Radiography | 1 | 2016 | 852 | 0.020 |
Why?
| | Keratin-15 | 1 | 2013 | 16 | 0.020 |
Why?
| | Denervation | 1 | 2013 | 27 | 0.020 |
Why?
| | Lac Operon | 1 | 2013 | 44 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2020 | 1505 | 0.020 |
Why?
| | Friend murine leukemia virus | 1 | 2013 | 31 | 0.020 |
Why?
| | Cellular Microenvironment | 1 | 2013 | 93 | 0.020 |
Why?
| | Cell Adhesion Molecules | 1 | 2013 | 181 | 0.020 |
Why?
| | Calcium-Binding Proteins | 1 | 2013 | 221 | 0.020 |
Why?
| | Mice, Nude | 1 | 2013 | 679 | 0.020 |
Why?
| | Glycoproteins | 1 | 2013 | 354 | 0.020 |
Why?
| | Neoplasm Proteins | 1 | 2013 | 441 | 0.020 |
Why?
| | Pulmonary Embolism | 1 | 2011 | 241 | 0.020 |
Why?
| | Odds Ratio | 1 | 2011 | 1082 | 0.020 |
Why?
| | Inflammation | 1 | 2020 | 2878 | 0.020 |
Why?
| | MutL Protein Homolog 1 | 1 | 2008 | 11 | 0.020 |
Why?
| | False Negative Reactions | 1 | 2008 | 61 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2188 | 0.020 |
Why?
| | Cohort Studies | 2 | 2008 | 6013 | 0.020 |
Why?
| | Incidence | 1 | 2014 | 2923 | 0.020 |
Why?
| | Peptides | 1 | 2013 | 998 | 0.020 |
Why?
| | Logistic Models | 1 | 2011 | 2134 | 0.010 |
Why?
| | Sex Factors | 1 | 2011 | 2105 | 0.010 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2008 | 425 | 0.010 |
Why?
| | Age Factors | 1 | 2011 | 3342 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2008 | 1246 | 0.010 |
Why?
| | DNA Methylation | 1 | 2008 | 674 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 2008 | 740 | 0.010 |
Why?
| | Young Adult | 2 | 2010 | 14218 | 0.010 |
Why?
| | Pregnancy | 1 | 2013 | 7202 | 0.010 |
Why?
| | Signal Transduction | 1 | 2013 | 5216 | 0.010 |
Why?
| | Hospitalization | 1 | 2008 | 2460 | 0.010 |
Why?
| | Mice | 1 | 2013 | 18329 | 0.010 |
Why?
| | Animals | 1 | 2013 | 38030 | 0.000 |
Why?
| | Adolescent | 1 | 2008 | 22529 | 0.000 |
Why?
|
|
Vogel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|